The Apolipoprotein A-I Mimetic L-4F Attenuates Monocyte Activation and Adverse Cardiac Remodeling after Myocardial Infarction
Excessive inflammation after myocardial infarction (MI) can promote infarct expansion and adverse left ventricular (LV) remodeling. L-4F, a mimetic peptide of apolipoprotein A-I (apoA-I), exhibits anti-inflammatory and anti-atherogenic properties; however, whether L-4F imparts beneficial effects aft...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/10/3519 |
id |
doaj-11071899cf14467f965cd7e7ca02b5df |
---|---|
record_format |
Article |
spelling |
doaj-11071899cf14467f965cd7e7ca02b5df2020-11-25T03:12:45ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-05-01213519351910.3390/ijms21103519The Apolipoprotein A-I Mimetic L-4F Attenuates Monocyte Activation and Adverse Cardiac Remodeling after Myocardial InfarctionTariq Hamid0Mohamed Ameen Ismahil1Shyam S. Bansal2Bindiya Patel3Mehak Goel4C. Roger White5G. M. Anantharamaiah6Sumanth D. Prabhu7Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USADivision of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USADivision of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USADivision of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USADivision of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USADivision of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USADivision of Gerontology, Geriatrics, and Palliative Care, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USADivision of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USAExcessive inflammation after myocardial infarction (MI) can promote infarct expansion and adverse left ventricular (LV) remodeling. L-4F, a mimetic peptide of apolipoprotein A-I (apoA-I), exhibits anti-inflammatory and anti-atherogenic properties; however, whether L-4F imparts beneficial effects after myocardial infarction (MI) is unknown. Here we demonstrate that L-4F suppresses the expansion of blood, splenic, and myocardial pro-inflammatory monocytes and macrophages in a mouse model of reperfused MI. Changes in immune cell profiles were accompanied by alleviation of post-MI LV remodeling and dysfunction. In vitro, L-4F also inhibited pro-inflammatory and glycolytic gene expression in macrophages. In summary, L-4F treatment prevents prolonged and excessive inflammation after MI, in part through modulation of pro-inflammatory monocytes and macrophages, and improves post-MI LV remodeling. These data suggest that L-4F could be a used as a therapeutic adjunct in humans with MI to limit inflammation and alleviate the progression to heart failure.https://www.mdpi.com/1422-0067/21/10/3519inflammationheart failurecardiac remodelingmacrophage polarity |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Tariq Hamid Mohamed Ameen Ismahil Shyam S. Bansal Bindiya Patel Mehak Goel C. Roger White G. M. Anantharamaiah Sumanth D. Prabhu |
spellingShingle |
Tariq Hamid Mohamed Ameen Ismahil Shyam S. Bansal Bindiya Patel Mehak Goel C. Roger White G. M. Anantharamaiah Sumanth D. Prabhu The Apolipoprotein A-I Mimetic L-4F Attenuates Monocyte Activation and Adverse Cardiac Remodeling after Myocardial Infarction International Journal of Molecular Sciences inflammation heart failure cardiac remodeling macrophage polarity |
author_facet |
Tariq Hamid Mohamed Ameen Ismahil Shyam S. Bansal Bindiya Patel Mehak Goel C. Roger White G. M. Anantharamaiah Sumanth D. Prabhu |
author_sort |
Tariq Hamid |
title |
The Apolipoprotein A-I Mimetic L-4F Attenuates Monocyte Activation and Adverse Cardiac Remodeling after Myocardial Infarction |
title_short |
The Apolipoprotein A-I Mimetic L-4F Attenuates Monocyte Activation and Adverse Cardiac Remodeling after Myocardial Infarction |
title_full |
The Apolipoprotein A-I Mimetic L-4F Attenuates Monocyte Activation and Adverse Cardiac Remodeling after Myocardial Infarction |
title_fullStr |
The Apolipoprotein A-I Mimetic L-4F Attenuates Monocyte Activation and Adverse Cardiac Remodeling after Myocardial Infarction |
title_full_unstemmed |
The Apolipoprotein A-I Mimetic L-4F Attenuates Monocyte Activation and Adverse Cardiac Remodeling after Myocardial Infarction |
title_sort |
apolipoprotein a-i mimetic l-4f attenuates monocyte activation and adverse cardiac remodeling after myocardial infarction |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1661-6596 1422-0067 |
publishDate |
2020-05-01 |
description |
Excessive inflammation after myocardial infarction (MI) can promote infarct expansion and adverse left ventricular (LV) remodeling. L-4F, a mimetic peptide of apolipoprotein A-I (apoA-I), exhibits anti-inflammatory and anti-atherogenic properties; however, whether L-4F imparts beneficial effects after myocardial infarction (MI) is unknown. Here we demonstrate that L-4F suppresses the expansion of blood, splenic, and myocardial pro-inflammatory monocytes and macrophages in a mouse model of reperfused MI. Changes in immune cell profiles were accompanied by alleviation of post-MI LV remodeling and dysfunction. In vitro, L-4F also inhibited pro-inflammatory and glycolytic gene expression in macrophages. In summary, L-4F treatment prevents prolonged and excessive inflammation after MI, in part through modulation of pro-inflammatory monocytes and macrophages, and improves post-MI LV remodeling. These data suggest that L-4F could be a used as a therapeutic adjunct in humans with MI to limit inflammation and alleviate the progression to heart failure. |
topic |
inflammation heart failure cardiac remodeling macrophage polarity |
url |
https://www.mdpi.com/1422-0067/21/10/3519 |
work_keys_str_mv |
AT tariqhamid theapolipoproteinaimimeticl4fattenuatesmonocyteactivationandadversecardiacremodelingaftermyocardialinfarction AT mohamedameenismahil theapolipoproteinaimimeticl4fattenuatesmonocyteactivationandadversecardiacremodelingaftermyocardialinfarction AT shyamsbansal theapolipoproteinaimimeticl4fattenuatesmonocyteactivationandadversecardiacremodelingaftermyocardialinfarction AT bindiyapatel theapolipoproteinaimimeticl4fattenuatesmonocyteactivationandadversecardiacremodelingaftermyocardialinfarction AT mehakgoel theapolipoproteinaimimeticl4fattenuatesmonocyteactivationandadversecardiacremodelingaftermyocardialinfarction AT crogerwhite theapolipoproteinaimimeticl4fattenuatesmonocyteactivationandadversecardiacremodelingaftermyocardialinfarction AT gmanantharamaiah theapolipoproteinaimimeticl4fattenuatesmonocyteactivationandadversecardiacremodelingaftermyocardialinfarction AT sumanthdprabhu theapolipoproteinaimimeticl4fattenuatesmonocyteactivationandadversecardiacremodelingaftermyocardialinfarction AT tariqhamid apolipoproteinaimimeticl4fattenuatesmonocyteactivationandadversecardiacremodelingaftermyocardialinfarction AT mohamedameenismahil apolipoproteinaimimeticl4fattenuatesmonocyteactivationandadversecardiacremodelingaftermyocardialinfarction AT shyamsbansal apolipoproteinaimimeticl4fattenuatesmonocyteactivationandadversecardiacremodelingaftermyocardialinfarction AT bindiyapatel apolipoproteinaimimeticl4fattenuatesmonocyteactivationandadversecardiacremodelingaftermyocardialinfarction AT mehakgoel apolipoproteinaimimeticl4fattenuatesmonocyteactivationandadversecardiacremodelingaftermyocardialinfarction AT crogerwhite apolipoproteinaimimeticl4fattenuatesmonocyteactivationandadversecardiacremodelingaftermyocardialinfarction AT gmanantharamaiah apolipoproteinaimimeticl4fattenuatesmonocyteactivationandadversecardiacremodelingaftermyocardialinfarction AT sumanthdprabhu apolipoproteinaimimeticl4fattenuatesmonocyteactivationandadversecardiacremodelingaftermyocardialinfarction |
_version_ |
1724648688471506944 |